STAT+: Bracing for another Fauci hearing
Plus: Democrats take on Trump over IVF, and Trump's White House releases a new science funding blueprint.
Read full article →Healthcare Policy
Latest Healthcare Policy news from across the web.
STAT+: GSK lays out plans to cut costs, pursue more late-stage drug trials
New GSK CEO Luke Miels outlined his strategy to help the company navigate a patent cliff and get on a path toward long-term growth.
Read full article →Amid U.S. funding cuts, the International AIDS Conference faces an uncertain future
Dr. Kenneth Ngure, president-elect of the International AIDS Society, says, "We have had very good scientific advances ... yet the funding cuts have also taken us back."
Read full article →STAT+: FDA staff reiterate concerns about Replimune skin cancer treatment
Regulators at the FDA have reiterated concerns that Replimmune does not have adequate data to support an approval of its investigational skin cancer treatment.
Read full article →STAT+: Pharmalittle: We’re reading about FDA views on a Duchenne drug, GSK cost savings, and more
The FDA said a Capricor stem cell treatment for Duchenne muscular dystrophy did not meet a Phase 3 trial's objectives — contrary to company claims
Read full article →STAT+: Three questions with Whoop’s new CMO
In this edition of STAT Health Tech: A chat with Whoop's new chief medical officer, an update on CMS health tech initiative, and more.
Read full article →Anthony Fauci’s pandemic-era diary entries
New data on American substance use, concerns of a global HIV resurgence, and more health news from Morning Rounds
Read full article →STAT+: Preliminary trial results suggest a path to a safer Alzheimer’s treatment
ProMIS Neurosciences is trying to design a safer amyloid-clearing drug for Alzheimer's. Early results suggest it might be on to something.
Read full article →Cuts to funds and staffing have slowed the response to the cyclospora outbreak
Recent cuts, especially to state and local health departments, are slowing and muddling the response to what's already a record year of outbreaks for diarrhea-causing cyclospora.
Read full article →New HIV treatment options offer some hope amid U.S. funding cuts
The 26th International AIDS conference convenes this week. U.S. funding for HIV/AIDS work is being delayed or cut altogether, but there are also promising treatments on the horizon.
Read full article →CMS evaluates one year of health tech progress, announces eight new pledge categories
One year after launching the CMS Health Tech Ecosystem, officials convened in D.C. to celebrate the Trump administration modernizing health technology.
Read full article →From ‘lost cause’ to gold rush: Biotechs swarm to cure AATD
Biotech companies are racing to cure alpha-1 antitrypsin deficiency, AATD, fueling patent disputes, startup defections, arbitration, and a U.S.-China rivalry.
Read full article →